PlainRecalls
FDA Drug Critical Class I Terminated

Atropine Sulfate 0.4 mg/ml Injection, USP, Total Dosage 0.8 mg per 2 mL, 3 mL pre-filled syringe, Rx Only. Pharmakon Pharmaceuticals, Inc., 14450 Getz Road, Noblesville, IN. NDC: 45183-0105-78.

Reported: September 3, 2014 Initiated: April 21, 2014 #D-1568-2014

Product Description

Atropine Sulfate 0.4 mg/ml Injection, USP, Total Dosage 0.8 mg per 2 mL, 3 mL pre-filled syringe, Rx Only. Pharmakon Pharmaceuticals, Inc., 14450 Getz Road, Noblesville, IN. NDC: 45183-0105-78.

Reason for Recall

Incorrect/ Undeclared Excipient: Contains undeclared benzyl alcohol.

Details

Recalling Firm
Pharmakon Pharmaceuticals
Units Affected
5 Syringes
Distribution
United States: TX, IL, MD, IN
Location
Noblesville, IN

Frequently Asked Questions

What product was recalled?
Atropine Sulfate 0.4 mg/ml Injection, USP, Total Dosage 0.8 mg per 2 mL, 3 mL pre-filled syringe, Rx Only. Pharmakon Pharmaceuticals, Inc., 14450 Getz Road, Noblesville, IN. NDC: 45183-0105-78.. Recalled by Pharmakon Pharmaceuticals. Units affected: 5 Syringes.
Why was this product recalled?
Incorrect/ Undeclared Excipient: Contains undeclared benzyl alcohol.
Which agency issued this recall?
This recall was issued by the FDA Drug on September 3, 2014. Severity: Critical. Recall number: D-1568-2014.